SCHEMBL22315409

SCHEMBL22315409

CCCNC(=O)C1CC(C)(C)N(O)C1(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.40
GAA P10253 2/20 0.40
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38
KMT2A Q03164 5/20 0.37
MEN1 O00255 4/20 0.37
KDM4E B2RXH2 3/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
BCHE P06276 1/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 1/20 0.34
ATM Q13315 1/20 0.34
EPHX1 P07099 1/20 0.33
NAAA Q02083 1/20 0.32
EPHX2 P34913 1/20 0.32
MMP1 P03956 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18545640 0.90 FPR3 (0.40) L3MBTL1GAAKMT2AMEN1KDM4E
SCHEMBL12846024 0.88 GAA (0.41) L3MBTL1GAAKMT2AMEN1KDM4E
SCHEMBL23784774 0.87 GAA (0.40) L3MBTL1GAAKMT2AKDM4EEPHX2
SCHEMBL21103465 0.87 GAA (0.40) L3MBTL1GAAKDM4EHPGDNAAA
SCHEMBL18545712 0.85 GAA (0.39) L3MBTL1GAAKMT2AKDM4E
SCHEMBL18545638 0.83 HSD17B10 (0.43) L3MBTL1GAAKMT2AMEN1KDM4E
SCHEMBL15158572 0.83 KDM4E (0.40) L3MBTL1GAAKDM4EALDH1A1SMN1; SMN2
SCHEMBL20464743 0.83 SIGMAR1 (0.37) L3MBTL1GAAKDM4E
SCHEMBL24565006 0.82 GAA (0.34) L3MBTL1GAA
SCHEMBL23784775 0.82 GAA (0.39) L3MBTL1GAACHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10881748-B2 Nitroxide containing amyloid binding agents for imaging and therapeutic uses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-01-05 US disclosed
US-20200246492-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10881748-B2 Nitroxide containing amyloid binding agents for imaging and therapeutic uses APP, APBA1, CRYAB L3MBTL1 3274/4885GAA 1175/4885CHRNB2 96/4885
US-20200246492-A1 NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES APP, APBA1, CRYAB L3MBTL1 3274/4885GAA 1175/4885CHRNB2 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.